Nanobiotix S.A. (NBTX) Stock Analysis
NASDAQHealthcareBiotechnology
What Nanobiotix S.A. does
Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma, various head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has established a strategic collaboration with LianBio for the development and commercialization of NBTXR3 within key Asian markets, specifically Greater China, South Korea, Singapore, and Thailand. Founded in 2003, the company's main operations are situated in Paris, France.
Key metrics
ETFs linked to NBTX
Broad-market and Healthcare sector ETFs an investor holding Nanobiotix S.A. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NBTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NBTX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Nanobiotix S.A.?
- Nanobiotix S.A. trades under the ticker NBTX on NASDAQ.
- Which exchange is NBTX listed on?
- NBTX is listed on NASDAQ.
- What sector does Nanobiotix S.A. operate in?
- Nanobiotix S.A. is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze NBTX in a portfolio?
- PortView shows NBTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.